Company Overview
Snapshot
Founded in January 2006 by Dr. Ilya Fine, Elfi-Tech operates with 11–50 employees. The company has raised $4.05 million across three funding rounds from two investors. In May 2019, Elfi-Tech secured a grant from EU Horizon 2020.
Business overview
Elfi-Tech develops non-invasive blood flow monitoring solutions for in-hospital and home care settings. Its core technology is a Hemodynamic-Peripheral Flow Patient Monitoring system, which utilizes a compact optical sensor based on miniaturized dynamic light scattering (mDLS) technology and advanced algorithms. This system provides continuous, non-invasive measurement of blood flow and other hemodynamic parameters, distinguishing it from traditional PPG sensors. The company's technology is designed for critical care conditions such as low perfusion, shock/sepsis, and bleeding, serving markets within the Health Tech & Life Sciences sector, specifically in Medical Devices and Digital Healthcare for patient remote monitoring.
Strategic signal
Elfi-Tech's selection as a finalist in the $2.25 million Nokia Sensing XCHALLENGE in August 2013 highlighted the innovative potential of its non-invasive monitoring technology. This recognition from a major technology player signaled early validation for Elfi-Tech's approach to physiological parameter measurement, suggesting its solutions could have a significant impact on remote health monitoring and diagnostics within the medical technology landscape.
Log in to access full profile ›Company Intelligence Q&A
- What is Elfi-Tech's core technology?
- Elfi-Tech's core technology is a non-invasive sensor based on Miniaturized Dynamic Light Scattering (mDLS) technology and proprietary signal processing algorithms. This sensor measures blood flow and other hemodynamic parameters, offering continuous monitoring capabilities.
- When was Elfi-Tech founded and by whom?
- Elfi-Tech was founded in January 2006 by Dr. Ilya Fine.
- What was a notable early recognition for Elfi-Tech's technology?
- In August 2013, Elfi-Tech was selected as a finalist in the $2.25 million Nokia Sensing XCHALLENGE, recognizing its innovative monitoring sensor.
- What is the primary application of Elfi-Tech's technology?
- Elfi-Tech's technology is primarily used for non-invasive blood flow monitoring in both in-hospital and home care settings, particularly for continuous monitoring during surgery, recovery, and critical care conditions like low perfusion, shock/sepsis, and bleeding.